
Sign up to save your podcasts
Or


Better use of technology, the transition from analogue to digital, and greater innovation are at the heart of the 10 Year Health Plan. This includes plans to make the NHS app a gateway to the entire NHS, integrate AI into clinical pathways, create a new Health Data Research Service, make genomic sequencing at birth universal, utilise wearable technology in treatments as standard, and to improve uptake and adoption of medicines.
What are the potential benefits of greater use of technology and innovation in the NHS? Are there any risks associated with this? How deliverable is the 10 Year Health Plan’s vision for the use of technology and innovation in the NHS? What are the barriers to greater adoption of technology and innovation more broadly? And how can these be overcome? How can investment in technology and innovation be protected and prioritised?
To discuss these questions and more, we were joined by an expert panel including:
This event was chaired by Nick Davies, Programme Director at the Institute for Government.
We would like to thank Novartis Pharmaceuticals UK for kindly supporting this event.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
By Institute for Government4.5
22 ratings
Better use of technology, the transition from analogue to digital, and greater innovation are at the heart of the 10 Year Health Plan. This includes plans to make the NHS app a gateway to the entire NHS, integrate AI into clinical pathways, create a new Health Data Research Service, make genomic sequencing at birth universal, utilise wearable technology in treatments as standard, and to improve uptake and adoption of medicines.
What are the potential benefits of greater use of technology and innovation in the NHS? Are there any risks associated with this? How deliverable is the 10 Year Health Plan’s vision for the use of technology and innovation in the NHS? What are the barriers to greater adoption of technology and innovation more broadly? And how can these be overcome? How can investment in technology and innovation be protected and prioritised?
To discuss these questions and more, we were joined by an expert panel including:
This event was chaired by Nick Davies, Programme Director at the Institute for Government.
We would like to thank Novartis Pharmaceuticals UK for kindly supporting this event.
Learn more about your ad choices. Visit podcastchoices.com/adchoices

31 Listeners

154 Listeners

151 Listeners

46 Listeners

111 Listeners

70 Listeners

111 Listeners

47 Listeners

20 Listeners

9 Listeners

42 Listeners

24 Listeners

124 Listeners

120 Listeners

21 Listeners